Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

Spectrum Presenting at Two Investor Conferences; September 10th and 11th

Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in September

Spectrum Pharmaceuticals (NASDAQ:SPPI)
Intraday Stock Chart
Today : Tuesday 3 September 2019

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, announced today that an overview of the company's business strategy and development-stage programs will be given at two upcoming conferences being held in New York on September 10th and September 11th.
• Rodman & Renshaw 21st Annual Global Investment Conference, Sponsored by H.C. Wainwright
When: Tuesday, September 10, 2019 at 9:10 AM ET
• Morgan Stanley 17th Annual Global Healthcare Conference
When: Wednesday, September 11, 2019 at 1:35 PM ET
The presentations will be webcast live and may be accessed by visiting Spectrum’s website at investor.sppirx.com/index.php/events-and-presentations.
https://ih.advfn.com/stock-market/NASDAQ/spectrum-pharmaceuticals-SPPI/stock-news/80649347/spectrum-pharmaceuticals-to-present-at-two-upcomin

I'm sure they'll go over the World Lung data in relation to the new pozi cohorts but the Street won't be impressed w that when the Sword of Damacles (pozi interim data, pozi top-line data, and to a lesser extent Rolontis BLA submission) is hanging over their head. Why they can't release pozi cohort 1 interim data I don't get. Lots of companies do it. One other piece of info that's good news since it would be an early surprise but prolly won't move the needle is Zenith20 cohort 3 finishing recruiting.